Delivery Order 36C24920D0058-36C24922N0044
Award Date 5/11/20
Potential Completion Date 9/30/22
Potential Value $80K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germantown, MD, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 22 of the U.S. Department of Veterans Affairs to Qiagen, LLC for the provision of QuantiFERON TB reagents. The contract has a ceiling value of $157,879.35 and a period of performance through March 31, 2017. Qiagen is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academia. Qiagen has provided a range...
- Qiagen, LLC, a Germantown, Maryland-based manufacturer of molecular diagnostics and scientific equipment, was awarded a $497,875.40 firm fixed-price purchase order by the Veterans Integrated Service Network 22 on June 6, 2022, with performance completing by August 5, 2023. This contract, which carries no set-aside designation, procures reagents to support clinical laboratory operations within the Department of Veterans Affairs. The award reflects Qiagen's established role as a critical...
- This federal contract award was issued by the Veterans Integrated Service Network 19 (VISN 19) of the U.S. Department of Veterans Affairs (VA) to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $35,436.45 contract is for the procurement of QuantiFERON reagents, which are used for tuberculosis testing. This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call order, with an ultimate completion date of August 31, 2028. Qiagen has provided similar...
- This is a federal contract award by the Department of Veterans Affairs (VA) to Qiagen, LLC, a division of Qiagen N.V. The contract is for the delivery of QuantiFERON TB reagents, which are used for the diagnosis of tuberculosis infection. The contract has a ceiling value of $233,051.18 and a period of performance through February 15, 2018. This award is a delivery order placed under Qiagen's existing General Services Administration (GSA) Multiple Award Schedule contract for in-vitro diagnostics,...
- This is a delivery order issued under a larger Indefinite Delivery, Indefinite Quantity (IDIQ) contract by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs (VA) to Qiagen, LLC, a division of the international diagnostics company Qiagen N.V. The order is for CTX Quantiferon reagents, a product used in tuberculosis testing, at a firm fixed price of $106,687.50. The period of performance runs through November 30, 2025. Qiagen is an experienced...
- This is a Firm Fixed Price Delivery Order awarded by the Veterans Integrated Service Network 17, a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The contract, valued at $106,687.50, is for the supply of QuantiFERON-TB Gold Plus reagents. It is an Indefinite Delivery, Indefinite Quantity (IDIQ) contract with a period of performance through November 30, 2026. The contract does not have a set-aside designation. Qiagen,...
- This is a delivery order awarded to Qiagen, LLC, a subsidiary of Qiagen N.V., by the Veterans Integrated Service Network 9 (VISN 9) of the U.S. Department of Veterans Affairs. The contract is for the provision of QuantiFERON TB Gold Plus reagents, which are used for tuberculosis testing. The contract has a firm fixed price of $124,285.77 and a period of performance through September 30, 2024. This award is associated with a larger indefinite delivery/indefinite quantity (IDIQ) contract that...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $0.00 firm fixed price delivery order against an indefinite-delivery/indefinite-quantity contract to Qiagen, LLC for Quantiferon and tubes. Qiagen, LLC is a subsidiary of Qiagen N.V. This order is for Quantiferon and tubes to support the agency's testing programs through September 30, 2021. No set-aside designation was applied to this award placed against an existing IDIQ contract...
- The Veterans Integrated Service Network 8 awarded a $217,834.65 firm fixed-price purchase order to Qiagen, LLC for QuantiFERON-TB Gold Plus reagents and controls. The contract, awarded April 16, 2024, with completion targeted for September 30, 2025, represents a task order issued under an existing blanket purchase agreement between Veterans Integrated Service Networks and Qiagen for tuberculosis testing supplies. This purchase order supports VA clinical laboratory operations and occupational...
- This federal contract award is for the supply of QuantiFERON TB Gold reference lab packs and tubes to the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 21. The $160,321.56 fixed-price delivery order was awarded on June 15, 2015 to Qiagen, LLC, a division of the international provider of molecular diagnostics and genomics solutions Qiagen N.V. The contract has a period of performance through July 31, 2016. Qiagen holds several indefinite delivery contracts and blanket...
- 36C24920D0058Indefinite Delivery Contract
- 36C24920D0058-36C24922N0044Delivery Order
Qiagen, LLC was awarded a $80,343.09 firm fixed price delivery order contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 to provide Quantiferon TB reagents and supplies. As the prime contractor, Qiagen will deliver the requested products to support tuberculosis screening and diagnosis efforts at locations within the Germantown, Maryland area. No set-aside provisions were specified for this award placed against an unspecified agency-wide vehicle. Parent company Qiagen N.V. is identified as the owner of Qiagen, LLC.
Generated 1/3/24, 3:25 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($143k) | 4/26/23 | |
| Not listed | Not listed | $223.6k | 10/1/21 |